We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

246 hedge funds and large institutions have $1.87B invested in Dr. Reddy's Laboratories in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 93 increasing their positions, 86 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

234% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $362K

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

8% more funds holding

Funds holding: 227246 (+19)

8% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 86

5% more capital invested

Capital invested by funds: $1.79B → $1.87B (+$81.5M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

56.07% less ownership

Funds ownership: 70.28%14.21% (-56%)

Holders
246
Holders Change
+19
Holders Change %
+8.37%
% of All Funds
3.24%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
36
Increased
93
Reduced
86
Closed
17
Calls
$1.21M
Puts
$362K
Net Calls
+$847K
Net Calls Change
+$346K
Name Holding Trade Value Shares
Change
Change in
Stake
IQI
76
Integrated Quantitative Investments
Washington
$1.84M +$1.75M +116,500 New
BNP Paribas Asset Management
77
BNP Paribas Asset Management
France
$1.84M
AAS
78
Avantax Advisory Services
Texas
$1.78M -$11.6K -775 -0.7%
QCM
79
Quantinno Capital Management
New York
$1.69M +$90.2K +6,004 +6%
GC
80
Guggenheim Capital
Illinois
$1.68M -$213K -14,182 -12%
HF
81
HRT Financial
New York
$1.66M +$1.32M +87,895 +516%
BP
82
Ballentine Partners
Massachusetts
$1.65M +$412K +27,455 +36%
Balyasny Asset Management
83
Balyasny Asset Management
Illinois
$1.64M +$675K +44,955 +76%
MIFH
84
Migdal Insurance & Financial Holdings
Israel
$1.57M -$864K -57,500 -37%
Amundi
85
Amundi
France
$1.56M +$353K +23,500 +31%
BG
86
Bellevue Group
Switzerland
$1.55M -$76.2K -5,075 -5%
BCI
87
Brinker Capital Investments
Pennsylvania
$1.49M -$125K -8,338 -8%
OPS
88
Orion Portfolio Solutions
Nebraska
$1.49M -$125K -8,338 -8%
Pathstone Holdings
89
Pathstone Holdings
New Jersey
$1.49M +$40.8K +2,718 +3%
Fidelity Investments
90
Fidelity Investments
Massachusetts
$1.46M +$210K +13,991 +18%
HSBC Holdings
91
HSBC Holdings
United Kingdom
$1.45M -$1.43M -95,475 -51%
VSQM
92
V-Square Quantitative Management
Illinois
$1.42M +$342K +22,779 +34%
SCM
93
Shelton Capital Management
Colorado
$1.38M +$4.51K +300 +0.3%
AI
94
Axiom Investors
Connecticut
$1.37M -$436K -29,000 -25%
BAMF
95
BI Asset Management Fondsmaeglerselskab
Denmark
$1.33M -$103K -6,832 -7%
SFA
96
Sequoia Financial Advisors
Ohio
$1.31M +$75.3K +5,014 +6%
SEI Investments
97
SEI Investments
Pennsylvania
$1.3M -$2.1K -140 -0.2%
Bank of New York Mellon
98
Bank of New York Mellon
New York
$1.29M -$426K -28,374 -26%
Victory Capital Management
99
Victory Capital Management
Texas
$1.29M
RWM
100
Ritholtz Wealth Management
New York
$1.27M -$97.3K -6,480 -7%

RDY Hedge Fund Activity: Q4 2024 in Review

246 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2024, worth a combined $1.87B — up 4.6% from $1.79B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new RDY positions and 17 closed out — a net gain of 19 holders — while 93 added to existing stakes and 86 trimmed.

The largest buyer was Millennium Management, adding an estimated $30.6M. The largest seller was Bank of America, cutting an estimated $35.7M.

  • 246 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2024, up from 227 in Q3 2024.
  • Funds reported $1.87B of Dr. Reddy's Laboratories stock for Q4 2024, up 4.6% quarter-over-quarter.
  • 36 funds opened new Dr. Reddy's Laboratories positions in Q4 2024 and 17 closed out, a net change of +19 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q4 2024 was Millennium Management, an estimated $30.6M added.
  • The largest Dr. Reddy's Laboratories seller in Q4 2024 was Bank of America, an estimated $35.7M sold.

Based on aggregated 13F filings for Q4 2024.